Barbara Itzel Diaz Eufracio

Mrs. Barbara Itzel Diaz Eufracio

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in ACS Omega
Verified
Journal Article
Closed access
NDNoemi Angeles Durán-Iturbide
Noemi Angeles Durán-Iturbide
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio
JMJose Medina-Franco
Jose Medina-Franco

17 January 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
BJBeatriz Angélica Pilón Jiménez
Beatriz Angélica Pilón Jiménez
FSFernanda I. Saldívar-González
Fernanda I. Saldívar-González
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio
JMJose Medina-Franco
Jose Medina-Franco
Compound databases of natural products have a major impact on drug discovery projects and other areas of research. The number of databases in the public domain with compounds with natural origins is increasing. Several countries, Brazil, France, Panama and, recently, Vietnam, have initiatives in place to construct and maintain compound databases that are representative of their diversity. In this proof-of-concept study, we discuss the first version of BIOFACQUIM, a novel compound database with natural products isolated and characterized in Mexico. We discuss its construction, curation, and a complete chemoinformatic characterization of the content and coverage in chemical space. The profile of physicochemical properties, scaffold content, and diversity, as well as structural diversity based on molecular fingerprints is reported. BIOFACQUIM is available for free.

18 June 2021 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
JMJose Medina-Franco
Jose Medina-Franco
NSNorberto Sánchez-Cruz
Norberto Sánchez-Cruz
EDGAR LÓPEZ LÓPEZEDGAR LÓPEZ LÓPEZ
EDGAR LÓPEZ LÓPEZ
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio

17 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio
JMJose Medina-Franco
Jose Medina-Franco
Protein–protein interaction (PPI) inhibitors have an increasing role in drug discovery. It is hypothesized that machine learning (ML) algorithms can classify or identify PPI inhibitors. This work describes the performance of different algorithms and molecular fingerprints used in chemoinformatics to develop a classification model to identify PPI inhibitors making the codes freely available to the community, particularly the medicinal chemistry research groups working with PPI inhibitors. We found that classification algorithms have different performances according to various features employed in the training process. Random forest (RF) models with the extended connectivity fingerprint radius 2 (ECFP4) had the best classification abilities compared to those models trained with ECFP6 o MACCS keys (166-bits). In general, logistic regression (LR) models had lower performance metrics than RF models, but ECFP4 was the representation most appropriate for LR. ECFP4 also generated models with high-performance metrics with support vector machines (SVM). We also constructed ensemble models based on the top-performing models. As part of this work and to help non-computational experts, we developed a pipeline code freely available.

14 February 2018 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio
OPOscar Palomino-Hernández
Oscar Palomino-Hernández
RHRichard A. Houghten
Richard A. Houghten
JMJose Medina-Franco
Jose Medina-Franco

18 June 2020 in Molecular Informatics
Verified
Journal Article
Closed access
PDF file
BEBarbara Itzel Diaz Eufracio
Barbara Itzel Diaz Eufracio
OPOscar Palomino‐Hernández
Oscar Palomino‐Hernández
AAAarón Arredondo‐Sánchez
Aarón Arredondo‐Sánchez
JMJose Medina-Franco
Jose Medina-Franco